p to a quarter of adults have experienced shoulder pain over the past year, and it represents the third most common musculoskeletal problem. 1 2 About half of those affected will recover completely within six months. 3 Pain beyond three months is associated with poorer recovery, disability, and reduced ability to work. 3 Subacromial pain is the most common form (up to 70%) of shoulder pain, and it can impair the ability to work or do household tasks. [4] [5] [6] Most patients presenting with subacromial pain, without a history of trauma, receive a diagnosis of subacromial pain syndrome (SAPS), shoulder impingement, or rotator cuff disease. Each of these labels describe similar clinical presentations, but there is inconsistency about how they are defined and overlap between these diagnoses. Here, we use the term SAPS (see box 1 for details of its presentation). This recommendation addresses the role of surgery for adults with symptoms lasting more than three months, who approach health professionals for treatment.
This BMJ Rapid Recommendation is in response to two recent trials 12 13 which found that subacromial decompression surgery provided no benefit over placebo surgery. The recommendation is based on two linked systematic reviews on benefits and harms of subacromial decompression surgery and minimally important differences in patient reported outcome measures for shoulder pain, function and quality of life. 14 15 The main infographic provides an overview of the relative and absolute benefits and harms of surgery in standard GRADE format. Box 2 shows all of the articles and evidence linked in this Rapid Recommendation package. Table 2 below shows evidence that has emerged since the publication of this article.
Current practice
First line treatment options for SAPS include simple analgesia such as paracetamol, non-steroidal antiinflammatory drugs (NSAIDs), glucocorticoid injections, and exercise therapy. 8 Subacromial acromial decompression surgery is a second line treatment option for patients with more longstanding symptoms. Current guidelines provide inconsistent recommendations (table 1) . Such surgery includes removal of the subacromial bursa (bursectomy) and removal of bone from the under surface of the acromion (acromioplasty). 8 Surgeons initially performed subacromial decompression surgery as an open procedure. It evolved to less invasive keyhole surgery: arthroscopy.
Despite trials dating back to 1993 18 and systematic reviews failing to demonstrate benefit from surgery, 19 the number of arthroscopies performed has risen dramatically, although there is substantial geographical variation. 20 21 There were 21 000 procedures performed in NHS hospitals in 2010, which cost approximately £50 million. 21 
Box 1 | Details of subacromial pain syndrome (SAPS)
Common symptoms-Pain at the upper outer arm when lifting the arm (classically a painful arc through shoulder abduction), difficulty moving the arm (especially with forward flexion, external rotation, and abduction), reduced strength in the arm, and sleep problems due to pain 7 8 Key differential diagnoses-Adhesive capsulitis ("frozen shoulder") and glenohumeral osteoarthritis 8 9 Imaging-Patients with SAPS can have degeneration and partial thickness rotator cuff tears or abnormalities in the subacromial bursa on imaging. These imaging findings are also common in people without symptoms 10 Pathophysiology-Remains poorly understood. Cadaver studies suggested that pain might occur from rotator cuff tendons being caught ("impinging") between the acromion or coracoacromial ligament and the humerus. 11 These studies provided the initial rationale for subacromial decompression surgery 
The evidence
What is the minimum difference in symptoms and function important to patients?
The systematic review of minimally important differences (MIDs) identified 22 original studies of 5562 patients. They reported results for 74 MID estimates judged to be of variable and mostly low credibility. 14 The most credible MID estimates were used to help interpret the results of the systematic review, as shown in the infographic.
The panel were, due to credible estimates, confident that patients valued What are the benefits and harms of subacromial decompression surgery? The linked systematic review and meta-analysis pooled data from seven randomised controlled trials with 1014 participants diagnosed with SAPS. 15 In general, the patients included in the trials are representative of patients with SAPS presenting to primary care centres and outpatient clinics (fig 2) . Participants were around 49 years (median) and had had symptoms for around two years (median).
Planned evaluation of trials at lower risk of bias
The panel planned to focus on evidence at lower risk of bias. Two trials included placebo surgery and were at low risk of bias. 12 13 At one year after treatment, they showed that surgery did not have meaningful benefit over placebo surgery:
• High certainty evidence for little or no effect on -Pain ( • Low certainty evidence for little or no effect on return to work (risk ratio 1.05 (0.89 to 1.23)). Similar results were seen at six months, two years, and at five year follow-up, with the latter supported by low certainty evidence due to imprecise estimates from unblinded trials. 15 Planned evaluation of surgery compared with exercise therapy This analysis compared subacromial decompression surgery (including postoperative exercise therapy) with exercise therapy alone. Six trials reported such comparisons, and all were at high risk of bias due to lack of blinding. Some had imprecise estimates of effect. Compared with exercise therapy, there was no important benefit of surgery on pain, function, quality of life, global perceived effect, and return to work. 15 About a third (32%) of all participants included in the trials continued to have more than minor symptoms (such as mild to moderate pain) at one year, irrespective of treatment. The average pain scores in the trials at two years were 1.6 to 3.0 units (0-10 scale), reflecting mild to moderate pain.
Harms
Potential harms from surgery were incompletely reported in the trials. The trials were also underpowered to detect rare events. There were around 12 more frozen shoulders per 1000 patients undergoing subacromial decompression surgery, based on the two placebo controlled trials (low certainty evidence).
Because harms data from randomised trials were anticipated to be so limited, the guideline panel requested the systematic review to include observational studies designed to evaluate harms after subacromial decompression surgery. 15 The systematic review assessed 140 publications in full text, of which four reported results from a large prospective cohort study from the United States considered to represent best current evidence on serious harms. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] This registry study investigated 30-day complications resulting in readmission to hospitals after mixed arthroscopic procedures including subacromial decompression surgery from 2006 to 2013. 9 23 HOW THIS RECOMMENDATION WAS CREATED Our international panel included patients with lived experience of shoulder pain and surgery, orthopaedic surgeons, physiotherapists, a rheumatologist, general internists, a general practitioner, epidemiologists, and methodologists. No person had financial conflicts of interest; intellectual and professional conflicts were minimised and managed (see appendix 1 on bmj.com for details of panel members and their competing interests). The panel initially decided on the scope of the recommendation and the outcomes that are most important to patients.
The panel identified the following important outcomes: pain, patient global perceived effect, physical function, participation in work and recreation activities, health related quality of life, development of full-thickness rotator cuff tears, and potential harms from surgery (such as frozen shoulder, death, infection, venous thromboembolism, and anaesthesia related events). This selection was also informed by the Outcome Measures in Rheumatology (OMERACT) preliminary shoulder trial core domain outcome set. 28 To inform the recommendation the panel members requested two systematic reviews addressing the following questions: 1 What is the smallest change in pain, function and quality of life that patients with shoulder conditions such as SAPS consider important-the minimally important difference-to make surgery worthwhile? Such patient-reported outcomes measures (PROMs) were measured with a variety of instruments in the trials and are challenging to interpret. 2 What are the benefits and harms of subacromial decompression surgery in patients with SAPS, as compared to placebo and nonoperative management strategies?
Parallel teams conducted these systematic reviews. 14 15 Another team updated a Cochrane systematic review synchronised with this BMJ Rapid Recommendation. 16 The panel asked the review team to explore potential subgroup effects for risk of bias in trials and different types of comparisons to surgery, such as exercise therapy.
The panel used this evidence and followed BMJ Rapid Recommendations procedures for creating a trustworthy recommendation. This includes the GRADE approach. The panel met by videoconference to discuss the evidence and formulate a recommendation (see appendix 2 on bmj.com). 29 30 The panel considered the balance of benefits, harms, and burdens of surgery versus placebo surgery and nonoperative treatments, the certainty of the evidence for each outcome, typical and expected variations in patient values and preferences, as well as feasibility and acceptability (practical issues). 23 Recommendations using GRADE can be strong or weak, for or against a course of action. 30 The panel made the recommendation from an individual patient's perspective assuming that all options were available and affordable to the patient. It does not take a public health, societal, or health payer perspective. Healthcare systems can adapt these recommendations by including costs and other key issues of relevance, contextualised to national and local circumstances. The risk of serious harms after mixed shoulder arthroscopic procedures was 0.5% (95% confidence interval 0.4% to 0.7%) during years 2006-11 and 0.6% (0.5% to 0.7%) during 2011-13. Reported harms included events such as major bleeding, deep infections, serious anaesthetic complications, venous thromboembolism, and peripheral nerve injury. The indirectness caused by inclusion of mixed arthroscopic shoulder procedures in the registry study results in moderate certainty evidence for estimated harms.
Understanding the recommendation
The panel concluded that almost all well informed patients would decline surgery and therefore made a strong recommendation against subacromial decompression surgery. The panel was confident that surgery provides no important benefit on pain, function, quality of life, and global perceived effect informed by moderate to high certainty evidence in a one year timeframe. Surgery also comes with burdens and the risk of harm (see main infographic).
Clinicians should not offer patients subacromial decompression surgery unprompted, and clinicians, public healthcare providers, and others should make efforts to educate the public regarding the ineffectiveness of surgery. Although we did not take costs and resources into account beyond direct costs to patients (such as out-ofpocket costs), surgery cannot be cost effective given the lack of important benefit, potential for harm, and associated costs. Figure 3 includes the practical issues linked to surgery, compared with physical therapy because this was the key comparison in the trials and a relevant treatment option. This would differ for other treatment options such as analgesia or injection.
Uncertainty
Clinicians and patients might question what other therapies could be offered to patients diagnosed with SAPS or rotator cuff disease and whether any therapy is effective. Here we recognise the limitation of our BMJ Rapid Recommendations, made to provide guidance on new evidence that might change practice. For guidance on treatment alternatives beyond surgery, we point readers to a clinically focused overview article and to guidelines with a broader scope (table 1). 8 The whole area of best management of SAPS is uncertain, as reflected in the following brief summary on available treatment options:
• Glucocorticoid injections and NSAIDs may provide moderate to small short term benefits on shoulder pain compared with placebo. 8 24 • Exercise, manual therapy, and electrotherapies are of uncertain benefit to patients compared with watchful waiting, and guidelines vary in their recommendations. 25 26 • A holistic approach to care, with appropriate communication including reassurance and education, is likely to benefit patients but is poorly studied. 27 Key research questions to inform decision makers and future guidelines include:
• What are the best strategies to de-implement inefficient and potentially harmful subacromial decompression surgery for SAPS?
• How can we educate patients and clinicians to understand and adopt evidence, particularly when it goes against accepted beliefs? Table 2 shows evidence that has emerged since the p ublication of this article. As new evidence is published, a group will assess the new evidence and make a judgement on the extent it is expected to alter the recommendation.
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